← FDA Drug Approvals (Drugs@FDA)

MESALAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2018-11-20

Drug application

FDA Application #

ANDA203574

Application type

Abbreviated New Drug Application (Generic)

Brand name

MESALAMINE

Generic name

Mesalamine

Active ingredients

MESALAMINE

Dosage form

TABLET, DELAYED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

MYLAN

First approval

2018-11-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown